Monocyte signal transduction receptors in active and latent tuberculosis

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Druszczynska, Magdalena ^a   Wlodarczyk, Marcin ^a   Janiszewska Drobinska, Beata ^b   Kielnierowski, Grzegorz ^b   Zawadzka, Joanna ^b   Kowalewicz Kulbat, Magdalena ^a   Fol, Marek ^a   Szpakowski, Piotr ^a   Rudnicka, Karolina ^a   Chmiela, Magdalena ^a   Rudnicka, Wieslawa ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b Regional Specialized Hospital of Tuberculosis Lung Diseases and Rehabilitation   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD14 ANTIGEN; CD18 ANTIGEN; CD206 PROTEIN; CELL PROTEIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CELL SURFACE RECEPTOR; FC RECEPTOR; LECTIN; MANNOSE BINDING LECTIN; MANNOSE RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; BCG VACCINATION; CELL MEMBRANE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HUMAN; HUMAN CELL; INFECTION RESISTANCE; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; AGED; DISEASE COURSE; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PROGNOSIS;

ADULT; AGED; ANTIGENS, CD18; BIOLOGICAL MARKERS; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; LATENT TUBERCULOSIS; LECTINS, C-TYPE; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MALE; MANNOSE-BINDING LECTINS; MIDDLE AGED; MONOCYTES; PROGNOSIS; RECEPTORS, CELL SURFACE; RECEPTORS, IGG; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; YOUNG ADULT;

MLCS; MLOWN;

EID: 84874543495     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/851452     Document Type: Article

References (61)

1. Leung A. N., Pulmonary tuberculosis: the essentials. Radiology 1999 210 2 307 322 2-s2.0-0032933693 (Pubitemid 29055294)
2. Joosten S. A., Goemann J. J., Sutherland J. S., Identification of biomarkers for tuberculosis disease using a novel dual-color RT-MLPA assay. Genes and Immunity 2012 13 71 82 10.1038/gene.2011.64
3. Dietrich J., Doherty T. M., Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development. Acta Pathologica, Microbiologica et Immunologica Scandinavica 2009 117 5-6 440 457 2-s2.0-65349123115 10.1111/j.1600-0463.2009.02458.x
4. WHO, Global Tuberculosis Control. 2011, http://whqlibdoc.who.int/ publications/2011/9789241564380-eng.pdf
5. Divangahi M., Chen M., Gan H., Desjardins D., Hickman T. T., Lee D. M., Fortune S., Behar S. M., Remold H. G., Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nature Immunology 2009 10 8 899 906 2-s2.0-67651171188 10.1038/ni.1758
6. Bowdish D. M. E., Sakamoto K., Kim M.-J., Kroos M., Mukhopadhyay S., Leifer C. A., Tryggvason K., Gordon S., Russell D. G., MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. PLoS Pathogens 2009 5 6 2-s2.0-67650904929 10.1371/journal.ppat.1000474 e1000474
7. Bernardo J., Billingslea A. M., Blumenthal R. L., Seetoo K. F., Simons E. R., Fenton M. J., Differential responses of human mononuclear phagocytes to mycobacterial lipoarabinomannans: role of CD14 and the mannose receptor. Infection and Immunity 1998 66 1 28 35 2-s2.0-0031985538 (Pubitemid 28018797)
8. Landmann R., Ludwig C., Obrist R., Obrecht J. P., Effect of cytokines and lipopolysaccharide on CD14 antigen expression in human monocytes and macrophages. Journal of Cellular Biochemistry 1991 47 4 317 329 2-s2.0-0026337944
9. Ivashkiv L., Inflammatory signaling in macrophages: transitions from acute to tolerant and alternative activation states. European Journal of Immunology 2011 41 2470 2525
10. Liew F. Y., Xu D., Brint E. K., O'Neill L. A. J., Negative regulation of toll-like receptor-mediated immune responses. Nature Reviews Immunology 2005 5 6 446 458 2-s2.0-20644450804 10.1038/nri1630 (Pubitemid 40835033)
11. Guenin-Macé L., Siméone R., Demangel C., Lipids of pathogenic mycobacteria: contributions to virulence and host immune suppression. Transboundary and Emerging Diseases 2009 56 6-7 255 268 2-s2.0-68149122260 10.1111/j.1865-1682.2009.01072.x
12. Simmons D. P., Canaday D. H., Liu Y., Li Q., Huang A., Boom W. H., Harding C. V., Mycobacterium tuberculosis and TLR2 agonists inhibit induction of type I IFN and class I MHC antigen cross processing by TLR9. Journal of Immunology 2010 185 4 2405 2415 2-s2.0-77956894324 10.4049/jimmunol.0904005
13. 152Confers responsiveness to both lipoarabinomannan and lipopolisacharide in a novel HL-60 cell bioassay. Journal of Immunology 1998 161 4244 4251 (Pubitemid 28469007)
14. Zhang D. E., Hetherington C. J., Gonzalez D. A., Chen H. M., Tenen D. G., Regulation of CD14 expression during monocytic differentiation induced with 1 25-dihydroxyvitamin D3. Journal of Immunology 1994 153 7 3276 3284 2-s2.0-0028168084
15. Schlesinger L. S., Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. Journal of Immunology 1993 150 7 2920 2930 2-s2.0-0027173039 (Pubitemid 23127541)
16. Schäfer G., Jacobs M., Wilkinson R. J., Brown G. D., Non-opsonic recognition of Mycobacterium tuberculosis by phagocytes. Journal of Innate Immunity 2009 1 3 231 243 2-s2.0-77953385980 10.1159/000173703
17. Schlesinger L. S., Hull S. R., Kaufman T. M., Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. Journal of Immunology 1994 152 8 4070 4079 2-s2.0-0028261589 (Pubitemid 24111079)
18. Schlesinger L. S., Kaufman T. M., Iyer S., Hull S. R., Marchiando L. K., Differences in mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages. Journal of Immunology 1996 157 10 4568 4575 2-s2.0-0030588707 (Pubitemid 126449378)
19. Berrington W. R., Hawn T. R., Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter? Immunological Reviews 2007 219 1 167 186 2-s2.0-34548559007 10.1111/j.1600-065X.2007.00545.x (Pubitemid 47390000)
20. Druszczyńska M., Strapagiel D., Kwiatkowska S., Kowalewicz-Kulbat M., Rózalska B., Chmiela M., Rudnicka W., Tuberculosis bacilli still posing a threat. Polymorphism of genes regulating anti-mycobacterial properties of macrophages. Polish Journal of Microbiology 2006 55 1 7 12 2-s2.0-33646484081
21. DesJardin L. E., Kaufman T. M., Potts B., Kutzbach B., Yi H., Schlesinger L. S., Mycobacterium tuberculosis -infected human macrophages exhibit enhanced cellular adhesion with increased expression of LFA-1 and ICAM-1 and reduced expression and/or function of complement receptors, Fc γ RII and the mannose receptor. Microbiology 2002 148 10 3161 3171 2-s2.0-0036772640 (Pubitemid 35243716)
22. Rudnicka W., English N., Farrant J., North M. E., Bryant A. E., Edwards A. J., Stackpoole A., Webster A. D. B., Balfour B. M., LFA-1-dependent OKT3-driven T cell clusters in common variable immunodeficiency. Clinical and Experimental Immunology 1992 87 1 46 52 2-s2.0-0026516670
23. Yoshida Y. O., Umemura M., Yahagi A., O'Brien R. L., Ikuta K., Kishihara K., Hara H., Nakae S., Iwakura Y., Matsuzaki G., Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung. Journal of Immunology 2010 184 8 4414 4422 2-s2.0-77952774172 10.4049/jimmunol.0903332
24. Ghosh S., Chackerian A. A., Parker C. M., Ballantyne Ch. M., Behar S. M., The LFA-1 adhesion molecule is required for protective immunity during pulmonary Mycobacterium tuberculosis infection. Journal of Immunology 2006 176 8 4914 4922 2-s2.0-33645764646
25. Oliveira-Nascimento L., Massari P., Wetzler L. M., The role of TLR2 in infection and immunity. Frontiers in Immunology 2012 3 1 17
26. Tapping R. I., Tobias P. S., Mycobacterial lipoarabinomannan mediates physical interactions between TLR1 and TLR2 to induce signaling. Journal of Endotoxin Research 2003 9 4 264 268 2-s2.0-0038448227 10.1179/096805103225001477 (Pubitemid 36874538)
27. Jimenez-Dalmaroni M. J., Xiao N., Corper A. L., Verdino P., Ainge G. D., Larsen D. S., Painter G. F., Rudd P. M., Dwek R. A., Hoebe K., Beutler B., Wilson I. A., Soluble CD36 ectodomain binds negatively charged diacylglycerol ligands and acts as a co-receptor for TLR2. PLoS ONE 2009 4 10 2-s2.0-70449580312 10.1371/journal.pone.0007411 e7411
28. Fol M., Chauhan A., Nair N. K., Maloney E., Moomey M., Jagannath C., Madiraju M. V. V. S., Rajagopalan M., Modulation of Mycobacterium tuberculosis proliferation by MtrA, an essential two-component response regulator. Molecular Microbiology 2006 60 3 643 657 2-s2.0-33645885336 10.1111/j.1365-2958.2006. 05137.x
29. Peterson P. K., Gekker G., Hu S., Sheng W. S., Anderson W. R., Ulevitch R. J., Tobias P. S., Gustafson K. V., Molitor T. W., Chao C. C., CD14 receptor-mediated uptake of nonopsonized Mycobacterium tuberculosis by human microglia. Infection and Immunity 1995 63 4 1598 1602 2-s2.0-0028920736
30. Shams H., Wizel B., Lakey D. L., Samten B., Vankayalapati R., Valdivia R. H., Kitchens R. L., Griffith D. E., Barnes P. F., The CD14 receptor does not mediate entry of Mycobacterium tuberculosis into human mononuclear phagocytes. FEMS Immunology & Medical Microbiology 2003 36 1-2 63 69 2-s2.0-0037448086 10.1016/S0928-8244(03)00039-7 (Pubitemid 36515085)
31. Ernst J. D., Macrophage receptors for Mycobacterium tuberculosis. Infection and Immunity 1998 66 4 1277 1281 2-s2.0-0032037616 (Pubitemid 128471479)
32. Schlesinger L. S., Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. Journal of Immunology 1993 150 7 2920 2930 2-s2.0-0027173039 (Pubitemid 23127541)
33. Kang P. B., Azad A. K., Torrelles J. B., Kaufman T. M., Beharka A., Tibesar E., DesJardin L. E., Schlesinger L. S., The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. Journal of Experimental Medicine 2005 202 7 987 999 2-s2.0-25844508945 10.1084/jem.20051239 (Pubitemid 41396898)
34. Stenger S., Immunological control of tuberculosis: role of tumour necrosis factor and more. Annals of the Rheumatic Diseases 2005 64 4 iv24 iv28 2-s2.0-27444432605 10.1136/ard.2005.042531 (Pubitemid 41532012)
35. Ottenhoff T. H. M., Kaufmann S. H. E., Vaccines against tuberculosis: where are we and where do we need to go? PLoS Pathogens 2012 8 e1002607
36. Zhang Y., Doerfler M., Lee T. C., Guillemin B., Rom W. N., Mechanisms of stimulation of interleukin-1 β and tumor necrosis factor by Mycobacterium tuberculosis components. The Journal of Clinical Investigation 1993 91 5 2076 2083 2-s2.0-0027176944 (Pubitemid 23141480)
37. Andersen P., Doherty T. M., Pai M., Weldingh K., The prognosis of latent tuberculosis: can disease be predicted? Trends in Molecular Medicine 2007 13 5 175 182 2-s2.0-34247555886 10.1016/j.molmed.2007.03.004 (Pubitemid 46687128)
38. Chu C. Q., Field M., Andrew E., Haskard D., Feldmann M., Maini R. N., Detection of cytokines at the site of tuberculin-induced delayed-type hypersensitivity in man. Clinical and Experimental Immunology 1992 90 3 522 529 2-s2.0-0026621671 (Pubitemid 23001826)
39. Pourshafie M. R., Sonnenfeld G., Treatment of an infected murine macrophage cell line (J774A.1) with interferon- γ but not tumor necrosis factor or live Mycobacterium intracellulare alone modulates the expression of adhesion molecules. Journal of Interferon and Cytokine Research 1997 17 2 69 75 2-s2.0-0031038737 (Pubitemid 27100284)
40. Turner J., Gonzalez-Juarrero M., Saunders B. M., Brooks J. V., Marietta P., Ellis D. L., Frank A. A., Cooper A. M., Orme I. M., Immunological basis for reactivation of tuberculosis in mice. Infection and Immunity 2001 69 3264 3270 (Pubitemid 32332225)
41. Saunders B. M., Britton W. J., Life and death in the granuloma: immunopathology of tuberculosis. Immunology and Cell Biology 2007 85 2 103 111 2-s2.0-33947172058 10.1038/sj.icb.7100027 (Pubitemid 46398725)
42. Chiacchio T., Petruccioli E., Vanini V., Higher frequency of T-cell response to M. tuberculosis latency antigen Rv2628 at the site of active tuberculosis disease than in peripheral blood. Plos One 2011 6 e27539
43. Pacheco E., Fonseca C., Montes C., Zabaleta J., García L. F., Arias M. A., CD14 gene promoter polymorphism in different clinical forms of tuberculosis. FEMS Immunology and Medical Microbiology 2004 40 3 207 213 2-s2.0-1642274761 10.1016/S0928-8244(03)00369-9 (Pubitemid 38368184)
44. Lawn S. D., Labeta M. O., Arias M., Acheampong J. W., Griffin G. E., Elevated serum concentrations of soluble CD14 in HIV- and HIV+ patients with tuberculosis in Africa: prolonged elevation during anti-tuberculosis treatment. Clinical and Experimental Immunology 2000 120 3 483 487 2-s2.0-0034121083 10.1046/j.1365-2249.2000.01246.x (Pubitemid 30365554)
45. Nores J. E., Bensussan A., Vita N., Soluble CD14 acts as a negative regulator of human T cell activation and function. European Journal of Immunology 1999 29 265 276 (Pubitemid 29043544)
46. Griga T., Klein W., Epplen J. T., Hebler U., Stachon A., May B., CD14 expression on monocytes and soluble CD14 plasma levels in correlation to the promotor polymorphism of the endotoxin receptor CD14 gene in patients with inactive Crohn's disease. Hepato-Gastroenterology 2005 52 63 808 811 2-s2.0-20644443295 (Pubitemid 40834609)
47. Lien E., Aukrust P., Sundan A., Müller F., Frøland S. S., Espevik T., Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events. Blood 1998 92 6 2084 2092 2-s2.0-0032530736 (Pubitemid 28446698)
48. Egerer K., Feist E., Rohr U., Pruss A., Burmester G. R., Dorner T., Increased serum soluble CD14, ICAM-1 and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus. Lupus 2000 9 8 614 621 2-s2.0-0033772472
49. Rupp J., Goepel W., Kramme E., Jahn J., Solbach W., Maass M., CD14 promoter polymorphism-159C > T is associated with susceptibility to chronic Chlamydia pneumoniae infection in peripheral blood monocytes. Genes and Immunity 2004 5 5 435 438 2-s2.0-4344675670 10.1038/sj.gene.6364112 (Pubitemid 39139773)
50. Durieux J. J., Vita N., Popescu O., Guette F., Calzada-Wack J., Munker R., Schmidt R. E., Lupker J., Ferrara P., Ziegler-Heitbrock H. W. L., Labeta M. O., The two soluble forms of the lipopolysaccharide receptor, CD14: characterization and release by normal human monocytes. European Journal of Immunology 1994 24 9 2006 2012 2-s2.0-0028049597 (Pubitemid 24276527)
51. Pan Z., Zhou L., Hetherington C. J., Zhang D. E., Hepatocytes contribute to soluble CD14 production, and CD14 expression is differentially regulated in hepatocytes and monocytes. The Journal of Biological Chemistry 2000 275 46 36430 36435 2-s2.0-0034680934 10.1074/jbc.M003192200
52. Jersmann H. P. A., Hii C. S. T., Hodge G. L., Ferrante A., Synthesis and surface expression of CD14 by human endothelial cells. Infection and Immunity 2001 69 1 479 485 2-s2.0-0035164011 10.1128/IAI.69.1.479-485.2001 (Pubitemid 32038347)
53. Bulut Y., Michelsen K. S., Hayrapetian L., Naiki Y., Spallek R., Singh M., Arditi M., Mycobacterium tuberculosis heat shock proteins use diverse toll-like receptor pathways to activate pro-inflammatory signals. The Journal of Biological Chemistry 2005 280 22 20961 20967 2-s2.0-20444387233 10.1074/jbc.M411379200 (Pubitemid 40805653)
54. Means T. K., Lien E., Yoshimura A., Wang S., Golenbock D. T., Fenton M. J., The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for toll-like receptors. Journal of Immunology 1999 163 12 6748 6755 2-s2.0-0032716031
55. Thoma-Uszynski S., Stenger S., Takeuchi O., Ochoa M. T., Engele M., Sieling P. A., Barnes P. F., Röllinghoff M., Bölcskei P. L., Wagner M., Akira S., Norgard M. V., Belisle J. T., Godowski P. J., Bloom B. R., Modlin R. L., Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 2001 291 5508 1544 1547 2-s2.0-0035936836 10.1126/science.291.5508.1544 (Pubitemid 32179220)
56. Yim J. J., Lee H. W., Lee H. S., Kim Y. W., Han S. K., Shim Y. S., Holland S. M., The association between microsatellite polymorphisms in intron II of the human Toll-like receptor 2 gene and tuberculosis among Koreans. Genes and Immunity 2006 7 2 150 155 2-s2.0-33644761926 10.1038/sj.gene.6364274 (Pubitemid 43336057)
57. Abel B., Thieblemont N., Quesniaux V. J. F., Brown N., Mpagi J., Miyake K., Bihl F., Ryffel B., Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. Journal of Immunology 2002 169 6 3155 3162 2-s2.0-0037105425 (Pubitemid 35013161)
58. Shin D.-M., Yuk J.-M., Lee H.-M., Lee S. H., Son J. W., Harding C. V., Kim J. M., Modlin R. L., Jo E. K., Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signalling. Cellular Microbiology 2010 12 11 1648 1665 2-s2.0-78651077774 10.1111/j.1462-5822.2010. 01497.x
59. Domínguez J., Souza-Galvão M. D., Ruiz-Manzano J., Latorre I., Prat C., Lacoma A., Milà C., Jiménez M. Á., Blanco S., Maldonado J., Altet N., Ausina V., T-cell responses to the Mycobacterium tuberculosis -specific antigens in active tuberculosis patients at the beginning, during, and after antituberculosis treatment. Diagnostic Microbiology and Infectious Disease 2009 63 1 43 51 2-s2.0-57349164065 10.1016/j. diagmicrobio.2008.09.010
60. Chee C. B. E., Barkham T. M. S., KhinMar K. W., Gan S. H., Wang Y. T., Quantitative T-cell interferon-gamma responses to Mycobacterium tuberculosis -specific antigens in active and latent tuberculosis. European Journal of Clinical Microbiology and Infectious Diseases 2009 28 6 667 670 2-s2.0-67349286436 10.1007/s10096-008-0670-8
61. Higuchi K., Harada N., Fukazawa K., Mori T., Relationship between whole-blood interferon-gamma responses and the risk of active tuberculosis. Tuberculosis 2008 88 3 244 248 2-s2.0-43049142193 10.1016/j.tube.2007.11.009